Company / Net Income
ANI Pharmaceuticals, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$78.3M
FY2025
5-year range
-$47.9M / $78.3M
FY2021-FY2025
Trend
+522.9%
vs FY2024
Sector context
#45 of 216
Health Care
What the data says
Net Income changed +523% YoY in FY2025, a notable deviation from the 9-year average annual change of +138%.
Based on SEC 10-K filings.
$78M in FY2025. Top quartile in the Health Care sector.
Improved from $19M to $78M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 216This company $78.3M Sector average $454.3M
▼
-82.8% below sector average
Key checks
Key Insights
- In FY2025, net income increased 522.9% year-over-year.
- Ranks #45 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $78.3M | +522.9% |
| FY2024 | -$18.5M | -198.6% |
| FY2023 | $18.8M | +139.2% |
| FY2022 | -$47.9M | -12.4% |
| FY2021 | -$42.6M | -88.9% |
| FY2020 | -$22.5M | -470.0% |
| FY2019 | $6.1M | -60.7% |
| FY2018 | $15.5M | +1540.0% |
| FY2017 | -$1.1M | -127.4% |
| FY2016 | $3.9M | +1207.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026